PER 13.0% 13.0¢ percheron therapeutics limited

Ann: Appointment of Non-Executive Director, page-4

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 1,187 Posts.
    lightbulb Created with Sketch. 389
    For mine, this paragraph sums it up well...

    In welcoming Mr. Goolsbee to the Board, Antisense Therapeutics Chairman Bob Moses said “I am extremely pleased that Bill has agreed to join our Board and I am confident he will provide significant practical, as well as strategic value to the Company. Bill’s extensive experience in various aspects of the biopharmaceutical industry is highly relevant to our Company, particularly with respect to assisting us to increase the value of the Company for our shareholders. He has been involved with drug development programs in therapeutics similar to ours and he has experience in the entire regulatory process required for drug development and approval. Bill has also overseen many successful corporate initiatives including M&A. Bill is a perfect fit for our Company”.
 
watchlist Created with Sketch. Add PER (ASX) to my watchlist
(20min delay)
Last
13.0¢
Change
0.015(13.0%)
Mkt cap ! $117.2M
Open High Low Value Volume
12.0¢ 13.5¢ 12.0¢ $612.7K 4.843M

Buyers (Bids)

No. Vol. Price($)
2 56662 13.0¢
 

Sellers (Offers)

Price($) Vol. No.
13.5¢ 600000 2
View Market Depth
Last trade - 16.10pm 11/10/2024 (20 minute delay) ?
PER (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.